Skip to content

Paysign PAYS Cumulative Cost Basis

Cumulative Cost Basis at other companies

U.S. Bancorp logo
U.S. BancorpUSB
$93M-54.4%
Haemonetics logo
HaemoneticsHAE
Fidelity National Information Services logo
Fidelity National Information ServicesFIS
Marqeta logo
MarqetaMQ
The Bancorp logo
The BancorpTBBK
BioLife Solutions logo
BioLife SolutionsBLFS

Other financials

Income statement

See full
Revenue$28.0M+50.8%
Gross profit$18.2M+55.8%
Operating income$6.7M+168%
Net income$5.4M+110%
EPS (diluted)$0.09+80.0%

Balance sheet

See full
Cash & equivalents$20.5M+200%
Total debt$12.1M-4.6%
Total equity$55.0M+40.1%
Total assets$312.7M+52.5%

Cash flow

See full
Operating cash flow$18.8M+411%
CapEx$266.5K+239%
Free cash flow$18.5M+403%

Valuation

See full
Market cap$431.59M+46.1%
Enterprise value$423.11M+40.4%
P/E41.5×-7.0×
P/S4.7×+0.1×

Profitability

See full
Gross margin60.4%+2.5pp
Operating margin12.6%+6.7pp
Net margin11.4%+1.8pp
FCF margin82.9%

Returns & leverage

See full
Return on equity22.1%+3.2pp
Debt / equity0.2×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Paysign in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Paysign’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Paysign's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Paysign's cumulative cost basis?
Paysign (PAYS) reported cumulative cost basis of $5.43M in Q1 2026.
How has Paysign's cumulative cost basis changed year-over-year?
Paysign's cumulative cost basis increased by 25.6% year-over-year, from $4.32M to $5.43M.
What is the long-term trend for Paysign's cumulative cost basis?
Over 5 years (2020 to 2025), Paysign's cumulative cost basis has grown at a 10.7% compound annual growth rate (CAGR), from $3.11M to $5.16M.